Small E - Search Results

1

Feasibility, safety, and acceptability of a remotely monitored exercise pilot CHAMP: A Clinical trial of High-intensity Aerobic and resistance exercise for Metastatic castrate-resistant Prostate cancer.

Kenfield SA, Van Blarigan EL, Panchal N, Bang A, Zhang L, Graff RE, Chen YH, Ryan CJ, Luke A, Newton RU, Tenggara I, Schultz B, Wang E, Lavaki E, Zuniga K, Pinto N, Borno H, Aggarwal R, Friedlander T, Koshkin VS, Harzstark A, Small E, Chan JM. Kenfield SA, et al. Among authors: small e. Cancer Med. 2021 Nov;10(22):8058-8070. doi: 10.1002/cam4.4324. Epub 2021 Oct 12. Cancer Med. 2021. PMID: 34636156 Free PMC article. Clinical Trial.

2

A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinoma.

Small EJ, Frye JW, Wilkinson MJ, Carroll PR, Ernest ML, Stagg RJ. Small EJ, et al. Cancer. 1994 Jun 1;73(11):2803-7. doi: 10.1002/1097-0142(19940601)73:11<2803::aid-cncr2820731124>3.0.co;2-6. Cancer. 1994. PMID: 8194022 Clinical Trial.

3

The antiandrogen withdrawal syndrome. Experience in a large cohort of unselected patients with advanced prostate cancer.

Small EJ, Srinivas S. Small EJ, et al. Cancer. 1995 Oct 15;76(8):1428-34. doi: 10.1002/1097-0142(19951015)76:8<1428::aid-cncr2820760820>3.0.co;2-t. Cancer. 1995. PMID: 8620419

4

A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium.

Small EJ, Fippin LJ, Ernest ML, Carroll PR. Small EJ, et al. Cancer. 1996 Oct 15;78(8):1775-80. doi: 10.1002/(sici)1097-0142(19961015)78:8<1775::aid-cncr18>3.0.co;2-v. Cancer. 1996. PMID: 8859191 Clinical Trial.

5

Simultaneous antiandrogen withdrawal and treatment with ketoconazole and hydrocortisone in patients with advanced prostate carcinoma.

Small EJ, Baron A, Bok R. Small EJ, et al. Cancer. 1997 Nov 1;80(9):1755-9. doi: 10.1002/(sici)1097-0142(19971101)80:9<1755::aid-cncr9>3.0.co;2-d. Cancer. 1997. PMID: 9351544 Clinical Trial.

6

Outpatient combination chemoimmunotherapy for patients with metastatic melanoma. Results of a phase I/II trial.

Kashani-Sabet M, Sagebiel RW, Collins HE, Glassberg AB, Allen RE, Leong SP, Small EJ. Kashani-Sabet M, et al. Among authors: small ej. Cancer. 1999 Nov 15;86(10):2160-5. doi: 10.1002/(sici)1097-0142(19991115)86:10<2160::aid-cncr40>3.0.co;2-w. Cancer. 1999. PMID: 10570447

7

Role of secondary hormonal therapy in the management of recurrent prostate cancer.

Ryan CJ, Small EJ. Ryan CJ, et al. Urology. 2003 Dec 29;62 Suppl 1:87-94. doi: 10.1016/j.urology.2003.10.002. Urology. 2003. PMID: 14747046

8

Advances in prostate cancer.

Ryan CJ, Small EJ. Ryan CJ, et al. Curr Opin Oncol. 2004 May;16(3):242-6. doi: 10.1097/00001622-200405000-00009. Curr Opin Oncol. 2004. PMID: 15069320 Review.

9

Progress in detection and treatment of prostate cancer.

Ryan CJ, Small EJ. Ryan CJ, et al. Curr Opin Oncol. 2005 May;17(3):257-60. doi: 10.1097/01.cco.0000155008.37524.8e. Curr Opin Oncol. 2005. PMID: 15818171 Review.

10

Secondary hormonal manipulations in prostate cancer.

Ryan CJ, Small EJ. Ryan CJ, et al. Curr Oncol Rep. 2005 May;7(3):228-33. doi: 10.1007/s11912-005-0078-x. Curr Oncol Rep. 2005. PMID: 15847715 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

803 results

Search Page

Filters